{"name":"Allogene Therapeutics","slug":"allogene-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZklZNXBBSi1YalNSSHVTTU9UaEFqZmtjUS1ybUliaG1RUXp0bEQtX1ZuVEN3c0RMY0ZIUlJGR0lzMldWZWZlUGhQTlVRcEgzTGFaQWw5cTFQTmVEQzF2bFVBY3luMU5fa0FuQjNyR2V0WXFZNjFpQ21DTmh5YmxKZ0RKMW1mNHlJcjdoZXBNUWpDcll1T2d0elpoY2NQZDNkeUVJQVY3cjluYnhHN3MyUkM0REJxUkZlQ2hr?oc=5","date":"2026-02-11","type":"trial","source":"Fierce Biotech","summary":"'The only thing that saves us is data': Allogeneic CAR-T biotechs fight for relevance as industry moves on - Fierce Biotech","headline":"'The only thing that saves us is data': Allogeneic CAR-T biotechs fight for relevance as industry moves on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQcTdsYVlJVHNQZUNfejdYdU9weUR0VUlfdkNDVXBnTTJVT2RBa3g2WFNmZUJwUFNzbTVqTWVCSUZHRzMwSTFteUh4NVJDZV9wU2hsQkJaNkNxZXpTdTR5R0MtMmN2Wk1TQjcyRGM3QjQ2S211emhhYnh0bDcweXlBSTFodjFWenVCSDdqVmotSm5sblkzSDJZVzZ1OW52bjNLZ1BLQU1ad3JUM3J2bjUxRTZLbnpCVE9XUXN0WXVJTmp0TUJUVHpIdHFMYnJnRkhnQm1rdUplLUhpSTkxYXFSeDlhTmFQQnBZUTVpMVpiU0t1ODJZUHZvbFNlXzhwak5IblJpcTNEeUpQV1Q1a2Nlb3QzODE?oc=5","date":"2025-10-28","type":"pipeline","source":"PR Newswire","summary":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE00NVU2WkJGVDEzX2N4VHdSZUgwYS0zQnVWSVg5SjM2bTBtSUdNc2ZKanpzdEFqWjhEM0I2OC01SXdGbzNYOU5XYk1JMjN4R0g2SGFV?oc=5","date":"2025-08-01","type":"pipeline","source":"FirstWord Pharma","summary":"Allogene's cell therapy conditioning mAb linked to patient death - FirstWord Pharma","headline":"Allogene's cell therapy conditioning mAb linked to patient death","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBxSVhMRTlacDNiUktTMmpzR0NkdHZCdk1iY1VZVUtaLXpTaW05RkxIVkpMVDluSkFDYVB4dkJOU0Z3QUZWTnVfVmlROVBGMmFNX004?oc=5","date":"2025-06-02","type":"pipeline","source":"FirstWord Pharma","summary":"ASCO25: CAR-Ts from Allogene, Gilead show early promise in solid tumours - FirstWord Pharma","headline":"ASCO25: CAR-Ts from Allogene, Gilead show early promise in solid tumours","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNZVA5YUhjdHFScVdWZlJfTWpSNndDU081eUFqZEZOU3RSOFl4OWRjR1N0UWlsVDRYd0FvN0NJU2o2bG1CSUdDYTFyRDYwaU9NNUZEdHRzb3VhV2Q2VUpsMGhUWFRyV3JFWFRYZzFpem9ZbVIySzQ4dWtKMjZKQkxyeDFjSUptb2lfWnc?oc=5","date":"2025-02-15","type":"pipeline","source":"The Pharma Letter","summary":"Allogene leaps on allogeneic CAR-T therapy success - The Pharma Letter","headline":"Allogene leaps on allogeneic CAR-T therapy success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOWmVVYnl6ZDJTM0RaUlRFTjZ2b3JkM0k5TFpEbTBJZkVGaVJPN25rY1hmTFp0YnB1MU5FUW9wR1JFeXlBd3pTWGtoQWVWSlFuWVdXM2ZHeWs3S0dQT285TTFDOFRDWFpNZEVIUzBWV21iQWpyWVBHbnhoZnR0MHN3V0Z6TlB5anZCekJwZkZBRDB2RnNuOG10dXQzQQ?oc=5","date":"2024-01-04","type":"pipeline","source":"BioPharma Dive","summary":"Allogene to shift strategy in bid to reposition CAR-T - BioPharma Dive","headline":"Allogene to shift strategy in bid to reposition CAR-T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNaUs1dFo5SDhFMkgwN2YwY2t3OXBxazZkaXEtbVFtSk55eVNGWFh2ZkFvNFV4OTVSSGtoeEtXTVQ1SjViQW8xc0lnWU9xaUJqTEUzQ2Y5bmlBeTlWc2xHcGp0OXFJeGxGTUFIOWZxcjhJZ0ZWTFMxZGplRHZpMjZMLUF6cVF5YXBxTk15Y3dnbl9hNFVub2I1R0hwcnlkbEFTbV9tTHh3aUVld2JWRFlsdUctdDQzSVlwUWdoNg?oc=5","date":"2023-04-20","type":"pipeline","source":"Allogene","summary":"Allogene Therapeutics Appoints Timothy Moore as Chief Technical Officer - Allogene","headline":"Allogene Therapeutics Appoints Timothy Moore as Chief Technical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPOGFEUHhIQlAyNEpZYlctaHM5ejZQVURwYnFuQ3lHZzJyX0JVLWZid3FFd2ZDZmQ3b3F2ai1qNy0zeFJPOHJsUzlSUXpUWnlKUTBKZmUxeHFwOGZ6SXBJV1JLY1Z3SVhYWTNvbW5Xck55MEYtMHJyS0ZLUGl4c3VwcnlfYm5sRVN4NGJkUldDR0Nnb0pkR3FvNGNIUXZJNnNkVFpHR0YxbXIzbHF6S3dlbERzRGtkMHNh?oc=5","date":"2023-01-03","type":"pipeline","source":"Allogene","summary":"Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development - Allogene","headline":"Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNTTBjRWFnbEI4NWNqQUdnOFRMX1c1MUlSdEdheVdQN01vbEd2aG5WaFRqT0IwOWRoR1EwME5vSnJaLTBzTDR5QUFuc3J0ak1XbTNZSnF6NTdXTWdRN285UzVLYkFNdzNFQnJPclk5TlJud3N0dURCa01OaU85bU1ic0NzdFhHak8tMFZZZ2g5YXowbDY2NkRPekFXeHB3WFFFaE5ja21nX3ZDYVNpMDNxZVluNA?oc=5","date":"2021-10-08","type":"regulatory","source":"drugdiscoverytrends.com","summary":"Allogene Therapeutics’ stock drops 46% after FDA puts hold on AlloCAR-T trials - drugdiscoverytrends.com","headline":"Allogene Therapeutics’ stock drops 46% after FDA puts hold on AlloCAR-T trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOMUt1Z3J0Qnc2OWxDYVY2cmtLT19FazRKcnNFTkllOUZoWVM0UkowTUt0S09jWUJaWkw4R3hIX2tUMWRLSEEtZGQxdGFDN0duS3VqcDk5cnJONkJud18tOFV4SkpDUFZVbjlvOXI0eE5DQ3BBMTR0bnNXMDM1eHZJTGtKd09Sc0N3dm1qYTM2cEVKaFljaV9MVjlzZnl2NlVBbThiVFRyT2dfQi1mMXlUWDdZRDBLdWF6RzhLeU5POTI4RzNLcklrTnktQQ?oc=5","date":"2021-06-21","type":"pipeline","source":"Business Wire","summary":"Allogene Overland Biopharm Appoints Shuyuan Yao as Chief Executive Officer - Business Wire","headline":"Allogene Overland Biopharm Appoints Shuyuan Yao as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOZC02YXFCbHlqNnJzRE9XaERnb1oxUXBWQkJfVk40dTBSOFlYR0pCUFZDamRXY3lpRlY3blJjZU50QjR3YnFSMV90bWhlNWlNNGZaVUFjd29HUW4tN3dtZF9RcklRVUxvTlJpMnlYcmRGcC1oR2dFNlpxTVR1Vy00RzVhN0xCaE9fYlpLMENPSDhGbVhsMTdwcnBGMER5NUVKbmV0UA?oc=5","date":"2020-01-31","type":"pipeline","source":"Life Science Leader","summary":"Allogene Therapeutics — The Juggernaut Built On Kite's Flight - Life Science Leader","headline":"Allogene Therapeutics — The Juggernaut Built On Kite's Flight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQblN2YV9fY3NZRmtsaDZ3cF8ycFE1V29xUU02cl9YdWY2dWs2Z01oSnYtRDdOVFVMQlItSDNCMk5nS19IOFctMGg0clF0aHhBUGZDVFdoMmRvZDF1N29CTzFsUFlFZDlnV3BHQTE0eDRlRHBxRFBiM3ZXWHlYYlQ1b2lTTVZvbTFqQzB0bWxJWUxrY3k2RFQzRmZRZEg2Qno5aEpodzVnbjJROVg0UGhCUHJaOWI?oc=5","date":"2018-04-03","type":"pipeline","source":"BioSpace","summary":"Former Kite Pharma Execs Launch Allogene Therapeutics with Pfizer Support and $300 Million - BioSpace","headline":"Former Kite Pharma Execs Launch Allogene Therapeutics with Pfizer Support and $300 Million","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}